findmyKOL

Marat Fudim, MD

Enriched profile

Associate Professor of Medicine (Cardiology) · Duke University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Durham, NC · Southeast · United StatesSpecialtyCardiovascular DiseaseFocusHeart Failure Treatment and Management+4
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceverified 2026Payments2021–2025NIH funding2021–2026

Marat Fudim is Associate Professor of Medicine (Cardiology) at Duke University School of Medicine. OpenAlex indexes 697 publications with 13,670 citations (h-index 56); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Marat Fudim, MD, is Associate Professor of Medicine (Cardiology) at Duke University School of Medicine / Duke Clinical Research Institute. The public record shows 697 publications with 13,670 citations (h-index 56), centered on Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Cardiac pacing and defibrillation studies. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 39 companies, 3 NIH-funded awards (2021–2026).

  • Top research focus: Heart Failure Treatment and Management
  • 9 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 39 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Heart Failure7 trialsPain1 trialChest Pain1 trialIron Deficiencies1 trialVentricular Remodeling1 trialInfluenza, Human1 trialRespiratory Syncytial Virus Infections1 trial

Research focus

OpenAlex concept fingerprint
Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiac pacing and defibrillation studiesMechanical Circulatory Support DevicesHeart Rate Variability and Autonomic Control

Drugs & molecules

across trials, industry payments and publications
Kerendiageneric · FinerenoneClinical trials—Industry payments42Publications—Inpefageneric · SotagliflozinClinical trials—Industry payments27Publications—Monoferricgeneric · Ferric derisomaltoseClinical trials—Industry payments12Publications—Furoscixgeneric · FurosemideClinical trials—Industry payments6Publications—Wegovygeneric · SemaglutideClinical trials—Industry payments6Publications—Jardiancegeneric · EmpagliflozinClinical trials—Industry payments5Publications—Farxigageneric · DapagliflozinClinical trials—Industry payments2Publications—Entrestogeneric · Sacubitril / valsartanClinical trials—Industry payments1Publications—Exparelgeneric · BupivacaineClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Endotronix, Inc.Clinical trials1Industry payments7ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments129Boston Scientific CorporationClinical trials—Industry payments98CVRx, Inc.Clinical trials—Industry payments80Medtronic, Inc.Clinical trials—Industry payments70Abbott LaboratoriesClinical trials—Industry payments59Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments49Novo Nordisk IncClinical trials—Industry payments48Impulse Dynamics (USA) Inc.Clinical trials—Industry payments29Lexicon Pharmaceuticals, Inc.Clinical trials—Industry payments29Novo Nordisk ASClinical trials—Industry payments20Edwards Lifesciences CorporationClinical trials—Industry payments14Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments13Daxor CorporationClinical trials—Industry payments12Pharmacosmos Therapeutics Inc.Clinical trials—Industry payments12ZOLL Respicardia, Inc.Clinical trials—Industry payments11Merck Sharp & Dohme LLCClinical trials—Industry payments9ZOLL Circulation IncClinical trials—Industry payments9Recor Medical IncClinical trials—Industry payments7E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments6Scpharmaceuticals Inc.Clinical trials—Industry payments6Terumo Medical CorporationClinical trials—Industry payments6Boehringer Ingelheim International GmbHClinical trials—Industry payments5Procyrion, Inc.Clinical trials—Industry payments5Analog Devices Inc.Clinical trials—Industry payments4Duke UniversityClinical trials4Industry payments—Chugai Pharmaceutical Co., Ltd.Clinical trials—Industry payments3Itamar Medical IncClinical trials—Industry payments3AstraZeneca Pharmaceuticals LPClinical trials—Industry payments2Axon Therapies, Inc.Clinical trials2Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
697publications

Distinct works indexed by OpenAlex, matched via ORCID; 55 in PubMed.

13,670citations

Total citations across indexed works.

56h-index

Hirsch index (OpenAlex). i10-index 242.

Clinical & industry

trials, payments and federal funding
9clinical trials

Investigator role on registered studies.

View trials ↓
39companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2021–2026

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

39 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    61.7%
    Aldosterone antagonist (MRA)14.1%
    Spironolactone91%Eplerenone9%
    Part D<11 patients
    Loop diuretic12.5%
    Furosemide57%Torsemide43%
    Part D≥23 patients

    + 9 more classes in this area

  • Metabolism & gastrointestinal

    31.3%
    SGLT2 inhibitor17.7%
    Jardiance51%Farxiga36%Inpefa13%
    Part D<11 patients
    GLP-1 receptor agonist12%
    Ozempic90%Mounjaro10%
    Part D<11 patients

    + 1 more class in this area

  • Blood & clotting

    5.7%
    Factor Xa inhibitor4.6%
    Eliquis100%
    Part D≥12 patients
    P2Y12 inhibitor1.1%
    Clopidogrel100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

3 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Robert J. Mentz83Stephen J. Greene69Abdul Mannan Khan Minhas59Andrew P. Ambrosy56Adrian F. Hernandez54Muhammad Shahzeb Khan45Husam M. Salah45Veraprapas Kittipibul45Adam D. DeVore41Jan Biegus40G. Michael Felker39Gregg C. Fonarow37Manesh R. Patel34Javed Butler33Vishal N. Rao31Jonathan P. Piccini27Piotr Ponikowski26Daniel Burkhoff26Muthiah Vaduganathan25Barry A. Borlaug23Dmitry Yaranov21Ambarish Pandey21Erin D. Michos21Jeroen Molinger21Paul A. Sobotka21Zoar J. Engelman20Renato D. Lópes20Sana M. Al‐Khatib20Robert Zymliński20Tamaz Shaburishvili20Gianluigi Savarese18William T. Abraham18Sanjiv J. Shah17Dmitry Abramov17Salim S. Virani16Gracjan Iwanek16John G.F. Cleland15Fouad Chouairi15Salik Nazir15Javed Butler15

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/marat-fudim-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Instagram

    instagram.com/marat.fudim

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • LinkedIn

    linkedin.com/in/marat-fudim-b5228525

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/profile/Marat-Fudim

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
  • X / Twitter

    x.com/FudimMarat

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/p/Cy3XEe5Limp

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
  • Apple Podcasts

    podcasts.apple.com/us/podcast/heart-failure-beat/id1497759201

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MHS

    Duke University

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
  • MD

    Heinrich Heine University Düsseldorf (Germany)

    2011
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
  • Board Certified

    Cardiovascular Disease, American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
  • Board Certified

    Internal Medicine, American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗
  • Board Certified

    Advanced Heart Failure and Transplant Cardiology, American Board of Internal Medicine

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org ↗

Editorial & leadership roles

journal and society appointments
  • Medical Director

    Heart Failure Research Unit, Duke Heart

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sites.duke.edu ↗
  • Medical Director

    Heart Failure Remote Monitoring, Duke Heart

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sites.duke.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Member

    Duke Clinical Research Institute

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu ↗
  • Adjunct Professor

    Cardiology, Wroclaw Medical University (Wroclaw, Poland), current

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
  • Medical Director

    Heart Failure Research Unit and Heart Failure Remote Monitoring, Duke Heart

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sites.duke.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.